| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/10/2006 | US7118873 Polynucleotides encoding cellular transporters and methods of use thereof |
| 10/10/2006 | US7118872 Used in detection, isolation, and/or purification |
| 10/10/2006 | US7118869 Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 10/10/2006 | US7118866 Heterodimeric receptor libraries using phagemids |
| 10/10/2006 | US7118863 Methods for detecting NTR3 nucleic acids by hybridization |
| 10/10/2006 | US7118859 Methods for inhibiting HIV-1 infection |
| 10/10/2006 | US7118856 Enzyme catalyst; polypeptides; crystal structure |
| 10/10/2006 | US7118853 Providing tumor sample; Detecting expression or activity of a gene encoding the polypeptide in tumor sample; classifying the tumor as belonging to a tumor subclass |
| 10/10/2006 | US7118758 antigens that stimulate protective antibodies against enterotoxigenic Escherichia coli; proteins encoded by cssA and cssB genes |
| 10/10/2006 | US7118756 Recombinant protective protein from Streptococcus pneumoniae |
| 10/10/2006 | US7118752 Administering to one or more malignant cells an effective amount of a peptide species comprising an E-domain of insulin-like growth factor I (IGF-I) |
| 10/10/2006 | US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA |
| 10/10/2006 | US7118749 Transferrin receptor genes |
| 10/10/2006 | US7118746 Conditioned cell culture medium compositions and methods of use |
| 10/10/2006 | US7118742 Ligand for herpes simplex virus entry mediator and methods of use |
| 10/10/2006 | US7118738 Recombinant pox virus for immunization against MUC1 tumor-associated antigen |
| 10/10/2006 | US7118737 Adjust pharmokinetics; ligation, binding, overlapping; nonimmunogenic; genetic engineering |
| 10/10/2006 | CA2274307C Hypersensitive response induced resistance in plants by seed treatment |
| 10/10/2006 | CA2262778C Conformationally constrained backbone cyclized somatostatin analogs |
| 10/10/2006 | CA2212887C Monoclonal antibody specific for .beta.a4 peptide |
| 10/10/2006 | CA2192324C Recombinant virus and related method of quantitating same |
| 10/08/2006 | CA2540736A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
| 10/08/2006 | CA2503932A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
| 10/05/2006 | WO2006105486A2 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 10/05/2006 | WO2006105426A2 Manufacturing process for the production of peptides grown in insect cell lines |
| 10/05/2006 | WO2006105392A2 Neuron targeting peptides |
| 10/05/2006 | WO2006105201A2 Conjugates comprised of fatty acid and hiv gp41-derived peptide |
| 10/05/2006 | WO2006104615A2 Influenza nucleic acids, polypeptides, and uses thereof |
| 10/05/2006 | WO2006104536A2 Polynucleotides encoding stem cell factor-like proteins |
| 10/05/2006 | WO2006104510A2 Water-soluble compound |
| 10/05/2006 | WO2006104306A1 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
| 10/05/2006 | WO2006104200A1 Fluorescent protein |
| 10/05/2006 | WO2006104099A1 RORα PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 10/05/2006 | WO2006103666A2 Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| 10/05/2006 | WO2006103494A2 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 10/05/2006 | WO2006103472A2 Soluble vox2 protein as immunoregulatory factor |
| 10/05/2006 | WO2006103429A2 High affinity hiv t cell receptors |
| 10/05/2006 | WO2006103421A2 Method for predicting the response to receptor tyrosine kinase inhibitors |
| 10/05/2006 | WO2006103406A1 Method of producing a set of mhc molecules |
| 10/05/2006 | WO2006103298A2 Blood coagulation fviii analogues |
| 10/05/2006 | WO2006103258A1 Method for improved isolation of recombinantly produced proteins |
| 10/05/2006 | WO2006103251A1 Use of proteins as demulsifying agents |
| 10/05/2006 | WO2006103106A1 Synthetic zinc finger peptide ligature for forming binding proteins configured in series for addressing specific regions of double-stranded dna (zinc finger probes) |
| 10/05/2006 | WO2006102979A2 Inflammation markers and combinations thereof as biochemical markers for cardiovascular diseases |
| 10/05/2006 | WO2006102767A1 Tuberculosis vaccine and method for making same |
| 10/05/2006 | WO2006081553A3 ANTI-MUC1 α/ß ANTIBODIES |
| 10/05/2006 | WO2006075084A3 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 10/05/2006 | WO2006072809A8 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions |
| 10/05/2006 | WO2006060148A3 Novel peptides that bind to the erythropoietin receptor |
| 10/05/2006 | WO2006054000A3 Mutated netrin-4, fragments thereof and their use as medicines |
| 10/05/2006 | WO2006020849A3 Mutant interleukin-15 polypeptides |
| 10/05/2006 | WO2006020748A3 Gfp-snap25 fluorescence release assay for botulinum toxin protease activity |
| 10/05/2006 | WO2006008097A3 Pef-ts expression units comprising corynebacterium glutamicum |
| 10/05/2006 | WO2005097168A3 Synthetic chemokines, methods of manufacture, and uses |
| 10/05/2006 | WO2005062942A3 Novel oligonucleotides and treating cardiac disorders by using the same |
| 10/05/2006 | WO2005047460A3 Long-wavelength fps |
| 10/05/2006 | WO2005014778A3 Dna vaccine expressing ha1 of equine-2 influenza virus |
| 10/05/2006 | WO2005002500A3 Inhibitors of coronavirus |
| 10/05/2006 | WO2004065576A3 Methods and compositions for the treatment of urological disorder using differential expressed polypeptides |
| 10/05/2006 | WO2004064774A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/05/2006 | WO2004058052A3 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 10/05/2006 | WO2004046317A3 Products and processes for modulating peptide-peptide binding domain interactions |
| 10/05/2006 | WO2004044163A3 Methods for identifying risk of melanoma and treatments thereof |
| 10/05/2006 | WO2004039832A3 Leptin-related peptides |
| 10/05/2006 | WO2004022705A3 Neurotransmission-associated proteins |
| 10/05/2006 | WO2004016736A3 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 10/05/2006 | WO2003087306A8 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 10/05/2006 | WO2003066834A3 Composition and method for modulating an inflammatory response |
| 10/05/2006 | WO2003004992A3 Mammalian sweet and amino acid heterodimeric taste receptors |
| 10/05/2006 | US20060225150 Nucleic acid molecules and other molecules associated with soybean cyst nematode resistance |
| 10/05/2006 | US20060225149 Transgenic plant comprising vector coding p.parasitica protein (PPR1) protein for propagating disease resistant plants; biological pest control; progenitor cells a vector is introduced into plant, growing a transgenic plant that expresses the nucleotide sequence |
| 10/05/2006 | US20060225148 Plastid transit peptides |
| 10/05/2006 | US20060224331 Protein fragment complementation assays for high-throughput and high-content screening |
| 10/05/2006 | US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes |
| 10/05/2006 | US20060223987 Neutrophil specific immunoglobulins for use in treatment and prevention of microbial infection |
| 10/05/2006 | US20060223985 Soybean 7S protein and process for producing the same |
| 10/05/2006 | US20060223984 Gamma-conopeptides |
| 10/05/2006 | US20060223775 Nucleotide sequence for treating cancer and infection |
| 10/05/2006 | US20060223772 Vectors comprising guinea pig CMV regulatory elements |
| 10/05/2006 | US20060223771 Nuclear factor kappaB inducing factor |
| 10/05/2006 | US20060223767 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene therapy |
| 10/05/2006 | US20060223758 Treating treating angiogenic disease by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; stability |
| 10/05/2006 | US20060223757 Applications in gene therapy, transgenic organisms, functional genomics, and other areas of cell and molecular biology. |
| 10/05/2006 | US20060223756 Endothelial cell specifically binding peptides |
| 10/05/2006 | US20060223755 biodrug having affinity to bacterial and fungal toxins, and especially to lipopolysaccharide or lipoteichoic acid; treating a fungal or bacterial infection; ear infection, upper respiratory infection, sinusitis, otitis |
| 10/05/2006 | US20060223754 Human TSLP polynucleotides |
| 10/05/2006 | US20060223753 exhibiting improved activity relative to the native insulin-like growth factor 1 and II polypeptide; The fusion component F is selected from the group consisting of a human IgG constant region, Fc domain, and heavy chain; muscle atrophy |
| 10/05/2006 | US20060223752 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell |
| 10/05/2006 | US20060223751 bactericide, fungicide; defensins |
| 10/05/2006 | US20060223750 Agents and methods for enhancing photodynamic therapy |
| 10/05/2006 | US20060223748 Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 10/05/2006 | US20060223744 Prostate specific antigens and uses thereof |
| 10/05/2006 | US20060223156 Controlled dissolution crosslinked protein in crystals |
| 10/05/2006 | US20060223145 Method for producing recombinant human interferon alpha 2b polypeptide in pichia pastoris |
| 10/05/2006 | US20060223144 Method for mass production of human pollicle stimulating hormone |
| 10/05/2006 | US20060223143 Methods and compositions for polypeptide engineering |
| 10/05/2006 | US20060223142 Extended cDNAs for secreted proteins |
| 10/05/2006 | US20060223141 Transcription amplification system for molecular imaging |
| 10/05/2006 | US20060223132 Phenethanolamine-derived haptens, immunogens, antibodies and conjugates |
| 10/05/2006 | US20060223123 nucleic acid encoding Macaca mulatta (rhesus monkey) Nur77 nuclear receptor (rhNur77); useful for treating or inhibiting inflammatory diseases such as osteoarthritis and various bone, neurological, and prostrate disorders, and cancer; drug screening; biodrug; culturing |